article thumbnail

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan

As life sciences companies aim to enhance patients’ treatment experiences and find new biomarkers that aid drug discovery, DTx companies diversify their pipelines by adding new indications, addressing unmet needs. billion in 2020, expanding exponentially at a compound annual growth rate (CAGR) of 29.8%. billion by 2025 from $1.23

article thumbnail

Life Sciences’ Contribution to the US Digital Therapeutics Market to Grow the Fastest amongst all End Users

Frost & Sullivan

As life sciences companies aim to enhance patients’ treatment experiences and find new biomarkers that aid drug discovery, DTx companies diversify their pipelines by adding new indications, addressing unmet needs. billion in 2020, expanding exponentially at a compound annual growth rate (CAGR) of 29.8%. billion by 2025 from $1.23

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

8 Growth Opportunities in the Healthcare and Life Sciences Industry to Watch Out for in 2021

Frost & Sullivan

February 8, 2021 – Due to the impact of the COVID-19 pandemic, 2020 was an unforgiving but transformational year for the healthcare industry. The post 8 Growth Opportunities in the Healthcare and Life Sciences Industry to Watch Out for in 2021 appeared first on Frost & Sullivan. Santa Clara, Calif. in 2019 to 1.8%

article thumbnail

Reflections on 2020 ASAP BioPharma Conference: The right mindset is more important than ever

Vantage Partners

Overview The 2020 ASAP BioPharma conference came to a close a month ago and marked another year of bringing together talented and thoughtful strategic alliance professionals to share and reflect on their experiences in this field.

article thumbnail

5 Strategic Insights Set to Power the Femtech Market

Frost & Sullivan

The global femtech market was valued at $487 million in 2020 and is expected to reach $522 million by the end of 2021. The time has come for female technology to become mainstream, as so far, women’s health is still in the shadows,” said Reenita Das, Partner and Global Client Leader, Healthcare & Life Sciences at Frost & Sullivan.

article thumbnail

Capgemini Applauded by Frost & Sullivan for Enabling Businesses in the Life Sciences Industry to Transform and Manage Their Processes with Its End-to-end Digital Transformation and Technology Services

Frost & Sullivan

. – January 11, 2022 – Frost & Sullivan analyzed global digital transformation services in the life sciences industry and, based on its findings, recognizes Capgemin i with the 2021 Global Company of the Year Award for digital transformation services within life sciences. Get The Future You Want | www.capgemini.com.

article thumbnail

Top 14 BioPharmaceutical Consultants & Consulting Firms

Jake Jorgovan

NGT BioPharma Consultants : A consultancy firm specializing in drug development and advanced technologies, offering comprehensive support from late discovery to life cycle management for both small molecules and biologics. Broad expertise in business and technical domains. Known for natural process improvement.